Global NSCLC Drugs Market Growth (Status and Outlook) 2025-2031

September 2025 | 112 pages | ID: GAC3FD1E1303EN
LP Information

Abstracts

According to this study, the global NSCLC Drugs market size will reach US$ million by 2031.

Some cancer cells have gene changes (also called mutations) that help them grow and spread. The NSCLC Drugs is to block those changes.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “NSCLC Drugs Industry Forecast” looks at past sales and reviews total world NSCLC Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected NSCLC Drugs sales for 2025 through 2031. With NSCLC Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world NSCLC Drugs industry.

This Insight Report provides a comprehensive analysis of the global NSCLC Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on NSCLC Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global NSCLC Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for NSCLC Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global NSCLC Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of NSCLC Drugs market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Oral Type
• Injection Type

Segmentation by Application:

• Squamous Cell Lung Carcinoma
• Large-cell Lung Carcinoma

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Merck
• Bristol-Myers Squibb
• Regeneron Pharmaceuticals
• Novartis
• Jiangsu Hengrui Medicine
• Innovent Biologics
• Shanghai Junshi Biosciences
• BeiGene
• Roche
• AstraZeneca
• Pfizer
• Boehringer-Ingelheim
• Teva

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global NSCLC Drugs Market Size (2020-2031)
  2.1.2 NSCLC Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for NSCLC Drugs by Country/Region (2020, 2024 & 2031)
2.2 NSCLC Drugs Segment by Type
  2.2.1 Oral Type
  2.2.2 Injection Type
2.3 NSCLC Drugs Market Size by Type
  2.3.1 NSCLC Drugs Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global NSCLC Drugs Market Size Market Share by Type (2020-2025)
2.4 NSCLC Drugs Segment by Application
  2.4.1 Squamous Cell Lung Carcinoma
  2.4.2 Large-cell Lung Carcinoma
2.5 NSCLC Drugs Market Size by Application
  2.5.1 NSCLC Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global NSCLC Drugs Market Size Market Share by Application (2020-2025)

3 NSCLC DRUGS MARKET SIZE BY PLAYER

3.1 NSCLC Drugs Market Size Market Share by Player
  3.1.1 Global NSCLC Drugs Revenue by Player (2020-2025)
  3.1.2 Global NSCLC Drugs Revenue Market Share by Player (2020-2025)
3.2 Global NSCLC Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 NSCLC DRUGS BY REGION

4.1 NSCLC Drugs Market Size by Region (2020-2025)
4.2 Global NSCLC Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas NSCLC Drugs Market Size Growth (2020-2025)
4.4 APAC NSCLC Drugs Market Size Growth (2020-2025)
4.5 Europe NSCLC Drugs Market Size Growth (2020-2025)
4.6 Middle East & Africa NSCLC Drugs Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas NSCLC Drugs Market Size by Country (2020-2025)
5.2 Americas NSCLC Drugs Market Size by Type (2020-2025)
5.3 Americas NSCLC Drugs Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC NSCLC Drugs Market Size by Region (2020-2025)
6.2 APAC NSCLC Drugs Market Size by Type (2020-2025)
6.3 APAC NSCLC Drugs Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe NSCLC Drugs Market Size by Country (2020-2025)
7.2 Europe NSCLC Drugs Market Size by Type (2020-2025)
7.3 Europe NSCLC Drugs Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa NSCLC Drugs by Region (2020-2025)
8.2 Middle East & Africa NSCLC Drugs Market Size by Type (2020-2025)
8.3 Middle East & Africa NSCLC Drugs Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL NSCLC DRUGS MARKET FORECAST

10.1 Global NSCLC Drugs Forecast by Region (2026-2031)
  10.1.1 Global NSCLC Drugs Forecast by Region (2026-2031)
  10.1.2 Americas NSCLC Drugs Forecast
  10.1.3 APAC NSCLC Drugs Forecast
  10.1.4 Europe NSCLC Drugs Forecast
  10.1.5 Middle East & Africa NSCLC Drugs Forecast
10.2 Americas NSCLC Drugs Forecast by Country (2026-2031)
  10.2.1 United States Market NSCLC Drugs Forecast
  10.2.2 Canada Market NSCLC Drugs Forecast
  10.2.3 Mexico Market NSCLC Drugs Forecast
  10.2.4 Brazil Market NSCLC Drugs Forecast
10.3 APAC NSCLC Drugs Forecast by Region (2026-2031)
  10.3.1 China NSCLC Drugs Market Forecast
  10.3.2 Japan Market NSCLC Drugs Forecast
  10.3.3 Korea Market NSCLC Drugs Forecast
  10.3.4 Southeast Asia Market NSCLC Drugs Forecast
  10.3.5 India Market NSCLC Drugs Forecast
  10.3.6 Australia Market NSCLC Drugs Forecast
10.4 Europe NSCLC Drugs Forecast by Country (2026-2031)
  10.4.1 Germany Market NSCLC Drugs Forecast
  10.4.2 France Market NSCLC Drugs Forecast
  10.4.3 UK Market NSCLC Drugs Forecast
  10.4.4 Italy Market NSCLC Drugs Forecast
  10.4.5 Russia Market NSCLC Drugs Forecast
10.5 Middle East & Africa NSCLC Drugs Forecast by Region (2026-2031)
  10.5.1 Egypt Market NSCLC Drugs Forecast
  10.5.2 South Africa Market NSCLC Drugs Forecast
  10.5.3 Israel Market NSCLC Drugs Forecast
  10.5.4 Turkey Market NSCLC Drugs Forecast
10.6 Global NSCLC Drugs Forecast by Type (2026-2031)
10.7 Global NSCLC Drugs Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market NSCLC Drugs Forecast

11 KEY PLAYERS ANALYSIS

11.1 Merck
  11.1.1 Merck Company Information
  11.1.2 Merck NSCLC Drugs Product Offered
  11.1.3 Merck NSCLC Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Merck Main Business Overview
  11.1.5 Merck Latest Developments
11.2 Bristol-Myers Squibb
  11.2.1 Bristol-Myers Squibb Company Information
  11.2.2 Bristol-Myers Squibb NSCLC Drugs Product Offered
  11.2.3 Bristol-Myers Squibb NSCLC Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Bristol-Myers Squibb Main Business Overview
  11.2.5 Bristol-Myers Squibb Latest Developments
11.3 Regeneron Pharmaceuticals
  11.3.1 Regeneron Pharmaceuticals Company Information
  11.3.2 Regeneron Pharmaceuticals NSCLC Drugs Product Offered
  11.3.3 Regeneron Pharmaceuticals NSCLC Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Regeneron Pharmaceuticals Main Business Overview
  11.3.5 Regeneron Pharmaceuticals Latest Developments
11.4 Novartis
  11.4.1 Novartis Company Information
  11.4.2 Novartis NSCLC Drugs Product Offered
  11.4.3 Novartis NSCLC Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Novartis Main Business Overview
  11.4.5 Novartis Latest Developments
11.5 Jiangsu Hengrui Medicine
  11.5.1 Jiangsu Hengrui Medicine Company Information
  11.5.2 Jiangsu Hengrui Medicine NSCLC Drugs Product Offered
  11.5.3 Jiangsu Hengrui Medicine NSCLC Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Jiangsu Hengrui Medicine Main Business Overview
  11.5.5 Jiangsu Hengrui Medicine Latest Developments
11.6 Innovent Biologics
  11.6.1 Innovent Biologics Company Information
  11.6.2 Innovent Biologics NSCLC Drugs Product Offered
  11.6.3 Innovent Biologics NSCLC Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Innovent Biologics Main Business Overview
  11.6.5 Innovent Biologics Latest Developments
11.7 Shanghai Junshi Biosciences
  11.7.1 Shanghai Junshi Biosciences Company Information
  11.7.2 Shanghai Junshi Biosciences NSCLC Drugs Product Offered
  11.7.3 Shanghai Junshi Biosciences NSCLC Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Shanghai Junshi Biosciences Main Business Overview
  11.7.5 Shanghai Junshi Biosciences Latest Developments
11.8 BeiGene
  11.8.1 BeiGene Company Information
  11.8.2 BeiGene NSCLC Drugs Product Offered
  11.8.3 BeiGene NSCLC Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 BeiGene Main Business Overview
  11.8.5 BeiGene Latest Developments
11.9 Roche
  11.9.1 Roche Company Information
  11.9.2 Roche NSCLC Drugs Product Offered
  11.9.3 Roche NSCLC Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Roche Main Business Overview
  11.9.5 Roche Latest Developments
11.10 AstraZeneca
  11.10.1 AstraZeneca Company Information
  11.10.2 AstraZeneca NSCLC Drugs Product Offered
  11.10.3 AstraZeneca NSCLC Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 AstraZeneca Main Business Overview
  11.10.5 AstraZeneca Latest Developments
11.11 Pfizer
  11.11.1 Pfizer Company Information
  11.11.2 Pfizer NSCLC Drugs Product Offered
  11.11.3 Pfizer NSCLC Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Pfizer Main Business Overview
  11.11.5 Pfizer Latest Developments
11.12 Boehringer-Ingelheim
  11.12.1 Boehringer-Ingelheim Company Information
  11.12.2 Boehringer-Ingelheim NSCLC Drugs Product Offered
  11.12.3 Boehringer-Ingelheim NSCLC Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Boehringer-Ingelheim Main Business Overview
  11.12.5 Boehringer-Ingelheim Latest Developments
11.13 Teva
  11.13.1 Teva Company Information
  11.13.2 Teva NSCLC Drugs Product Offered
  11.13.3 Teva NSCLC Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 Teva Main Business Overview
  11.13.5 Teva Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. NSCLC Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. NSCLC Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oral Type
Table 4. Major Players of Injection Type
Table 5. NSCLC Drugs Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global NSCLC Drugs Market Size by Type (2020-2025) & ($ millions)
Table 7. Global NSCLC Drugs Market Size Market Share by Type (2020-2025)
Table 8. NSCLC Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global NSCLC Drugs Market Size by Application (2020-2025) & ($ millions)
Table 10. Global NSCLC Drugs Market Size Market Share by Application (2020-2025)
Table 11. Global NSCLC Drugs Revenue by Player (2020-2025) & ($ millions)
Table 12. Global NSCLC Drugs Revenue Market Share by Player (2020-2025)
Table 13. NSCLC Drugs Key Players Head office and Products Offered
Table 14. NSCLC Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global NSCLC Drugs Market Size by Region (2020-2025) & ($ millions)
Table 18. Global NSCLC Drugs Market Size Market Share by Region (2020-2025)
Table 19. Global NSCLC Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global NSCLC Drugs Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas NSCLC Drugs Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas NSCLC Drugs Market Size Market Share by Country (2020-2025)
Table 23. Americas NSCLC Drugs Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas NSCLC Drugs Market Size Market Share by Type (2020-2025)
Table 25. Americas NSCLC Drugs Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas NSCLC Drugs Market Size Market Share by Application (2020-2025)
Table 27. APAC NSCLC Drugs Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC NSCLC Drugs Market Size Market Share by Region (2020-2025)
Table 29. APAC NSCLC Drugs Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC NSCLC Drugs Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe NSCLC Drugs Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe NSCLC Drugs Market Size Market Share by Country (2020-2025)
Table 33. Europe NSCLC Drugs Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe NSCLC Drugs Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa NSCLC Drugs Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa NSCLC Drugs Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa NSCLC Drugs Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of NSCLC Drugs
Table 39. Key Market Challenges & Risks of NSCLC Drugs
Table 40. Key Industry Trends of NSCLC Drugs
Table 41. Global NSCLC Drugs Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global NSCLC Drugs Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global NSCLC Drugs Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global NSCLC Drugs Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Merck Details, Company Type, NSCLC Drugs Area Served and Its Competitors
Table 46. Merck NSCLC Drugs Product Offered
Table 47. Merck NSCLC Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Merck Main Business
Table 49. Merck Latest Developments
Table 50. Bristol-Myers Squibb Details, Company Type, NSCLC Drugs Area Served and Its Competitors
Table 51. Bristol-Myers Squibb NSCLC Drugs Product Offered
Table 52. Bristol-Myers Squibb NSCLC Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Bristol-Myers Squibb Main Business
Table 54. Bristol-Myers Squibb Latest Developments
Table 55. Regeneron Pharmaceuticals Details, Company Type, NSCLC Drugs Area Served and Its Competitors
Table 56. Regeneron Pharmaceuticals NSCLC Drugs Product Offered
Table 57. Regeneron Pharmaceuticals NSCLC Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Regeneron Pharmaceuticals Main Business
Table 59. Regeneron Pharmaceuticals Latest Developments
Table 60. Novartis Details, Company Type, NSCLC Drugs Area Served and Its Competitors
Table 61. Novartis NSCLC Drugs Product Offered
Table 62. Novartis NSCLC Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Novartis Main Business
Table 64. Novartis Latest Developments
Table 65. Jiangsu Hengrui Medicine Details, Company Type, NSCLC Drugs Area Served and Its Competitors
Table 66. Jiangsu Hengrui Medicine NSCLC Drugs Product Offered
Table 67. Jiangsu Hengrui Medicine NSCLC Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Jiangsu Hengrui Medicine Main Business
Table 69. Jiangsu Hengrui Medicine Latest Developments
Table 70. Innovent Biologics Details, Company Type, NSCLC Drugs Area Served and Its Competitors
Table 71. Innovent Biologics NSCLC Drugs Product Offered
Table 72. Innovent Biologics NSCLC Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Innovent Biologics Main Business
Table 74. Innovent Biologics Latest Developments
Table 75. Shanghai Junshi Biosciences Details, Company Type, NSCLC Drugs Area Served and Its Competitors
Table 76. Shanghai Junshi Biosciences NSCLC Drugs Product Offered
Table 77. Shanghai Junshi Biosciences NSCLC Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Shanghai Junshi Biosciences Main Business
Table 79. Shanghai Junshi Biosciences Latest Developments
Table 80. BeiGene Details, Company Type, NSCLC Drugs Area Served and Its Competitors
Table 81. BeiGene NSCLC Drugs Product Offered
Table 82. BeiGene NSCLC Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. BeiGene Main Business
Table 84. BeiGene Latest Developments
Table 85. Roche Details, Company Type, NSCLC Drugs Area Served and Its Competitors
Table 86. Roche NSCLC Drugs Product Offered
Table 87. Roche NSCLC Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Roche Main Business
Table 89. Roche Latest Developments
Table 90. AstraZeneca Details, Company Type, NSCLC Drugs Area Served and Its Competitors
Table 91. AstraZeneca NSCLC Drugs Product Offered
Table 92. AstraZeneca NSCLC Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. AstraZeneca Main Business
Table 94. AstraZeneca Latest Developments
Table 95. Pfizer Details, Company Type, NSCLC Drugs Area Served and Its Competitors
Table 96. Pfizer NSCLC Drugs Product Offered
Table 97. Pfizer NSCLC Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Pfizer Main Business
Table 99. Pfizer Latest Developments
Table 100. Boehringer-Ingelheim Details, Company Type, NSCLC Drugs Area Served and Its Competitors
Table 101. Boehringer-Ingelheim NSCLC Drugs Product Offered
Table 102. Boehringer-Ingelheim NSCLC Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Boehringer-Ingelheim Main Business
Table 104. Boehringer-Ingelheim Latest Developments
Table 105. Teva Details, Company Type, NSCLC Drugs Area Served and Its Competitors
Table 106. Teva NSCLC Drugs Product Offered
Table 107. Teva NSCLC Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Teva Main Business
Table 109. Teva Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. NSCLC Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global NSCLC Drugs Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. NSCLC Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. NSCLC Drugs Sales Market Share by Country/Region (2024)
Figure 8. NSCLC Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global NSCLC Drugs Market Size Market Share by Type in 2024
Figure 10. NSCLC Drugs in Squamous Cell Lung Carcinoma
Figure 11. Global NSCLC Drugs Market: Squamous Cell Lung Carcinoma (2020-2025) & ($ millions)
Figure 12. NSCLC Drugs in Large-cell Lung Carcinoma
Figure 13. Global NSCLC Drugs Market: Large-cell Lung Carcinoma (2020-2025) & ($ millions)
Figure 14. Global NSCLC Drugs Market Size Market Share by Application in 2024
Figure 15. Global NSCLC Drugs Revenue Market Share by Player in 2024
Figure 16. Global NSCLC Drugs Market Size Market Share by Region (2020-2025)
Figure 17. Americas NSCLC Drugs Market Size 2020-2025 ($ millions)
Figure 18. APAC NSCLC Drugs Market Size 2020-2025 ($ millions)
Figure 19. Europe NSCLC Drugs Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa NSCLC Drugs Market Size 2020-2025 ($ millions)
Figure 21. Americas NSCLC Drugs Value Market Share by Country in 2024
Figure 22. United States NSCLC Drugs Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada NSCLC Drugs Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico NSCLC Drugs Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil NSCLC Drugs Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC NSCLC Drugs Market Size Market Share by Region in 2024
Figure 27. APAC NSCLC Drugs Market Size Market Share by Type (2020-2025)
Figure 28. APAC NSCLC Drugs Market Size Market Share by Application (2020-2025)
Figure 29. China NSCLC Drugs Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan NSCLC Drugs Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea NSCLC Drugs Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia NSCLC Drugs Market Size Growth 2020-2025 ($ millions)
Figure 33. India NSCLC Drugs Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia NSCLC Drugs Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe NSCLC Drugs Market Size Market Share by Country in 2024
Figure 36. Europe NSCLC Drugs Market Size Market Share by Type (2020-2025)
Figure 37. Europe NSCLC Drugs Market Size Market Share by Application (2020-2025)
Figure 38. Germany NSCLC Drugs Market Size Growth 2020-2025 ($ millions)
Figure 39. France NSCLC Drugs Market Size Growth 2020-2025 ($ millions)
Figure 40. UK NSCLC Drugs Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy NSCLC Drugs Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia NSCLC Drugs Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa NSCLC Drugs Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa NSCLC Drugs Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa NSCLC Drugs Market Size Market Share by Application (2020-2025)
Figure 46. Egypt NSCLC Drugs Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa NSCLC Drugs Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel NSCLC Drugs Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey NSCLC Drugs Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries NSCLC Drugs Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas NSCLC Drugs Market Size 2026-2031 ($ millions)
Figure 52. APAC NSCLC Drugs Market Size 2026-2031 ($ millions)
Figure 53. Europe NSCLC Drugs Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa NSCLC Drugs Market Size 2026-2031 ($ millions)
Figure 55. United States NSCLC Drugs Market Size 2026-2031 ($ millions)
Figure 56. Canada NSCLC Drugs Market Size 2026-2031 ($ millions)
Figure 57. Mexico NSCLC Drugs Market Size 2026-2031 ($ millions)
Figure 58. Brazil NSCLC Drugs Market Size 2026-2031 ($ millions)
Figure 59. China NSCLC Drugs Market Size 2026-2031 ($ millions)
Figure 60. Japan NSCLC Drugs Market Size 2026-2031 ($ millions)
Figure 61. Korea NSCLC Drugs Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia NSCLC Drugs Market Size 2026-2031 ($ millions)
Figure 63. India NSCLC Drugs Market Size 2026-2031 ($ millions)
Figure 64. Australia NSCLC Drugs Market Size 2026-2031 ($ millions)
Figure 65. Germany NSCLC Drugs Market Size 2026-2031 ($ millions)
Figure 66. France NSCLC Drugs Market Size 2026-2031 ($ millions)
Figure 67. UK NSCLC Drugs Market Size 2026-2031 ($ millions)
Figure 68. Italy NSCLC Drugs Market Size 2026-2031 ($ millions)
Figure 69. Russia NSCLC Drugs Market Size 2026-2031 ($ millions)
Figure 70. Egypt NSCLC Drugs Market Size 2026-2031 ($ millions)
Figure 71. South Africa NSCLC Drugs Market Size 2026-2031 ($ millions)
Figure 72. Israel NSCLC Drugs Market Size 2026-2031 ($ millions)
Figure 73. Turkey NSCLC Drugs Market Size 2026-2031 ($ millions)
Figure 74. Global NSCLC Drugs Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global NSCLC Drugs Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries NSCLC Drugs Market Size 2026-2031 ($ millions)